GlassScriptPhysician profile
Thomas G Foreman
NPI 1942284047
$1,939.86
in general payments reported to CMS, 2019-2025
11 companies · $477 in 2025
The $477 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $236 · 2020: $180 · 2021: $85.90 · 2022: $79.82 · 2023: $512 · 2024: $369 · 2025: $477.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,359.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,358.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $580.34 | 2019-2025 | Grafix Pl, Oasis, Pico |
| Organogenesis INC. | $383.93 | 2020-2025 | Apligraf, Puraply, Puraply Wound Matrix |
| Kerecis Limited | $278.54 | 2023-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Next Science LLC | $236.94 | 2023 | Xperience, Blastx, Surgx |
| Integra Lifesciences Corporation | $130.14 | 2019-2024 | Tcc-Ez |
| Misonix INC | $99.82 | 2020-2021 | |
| Kci USA, INC. | $76.90 | 2020 | |
| Osiris Therapeutics INC. | $56.49 | 2019 | |
| Bioventus LLC | $41.71 | 2022 | |
| Averitas Pharma INC. | $28.68 | 2024 | Qutenza |
| Ovik Health, LLC | $26.37 | 2019-2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Foreman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.